NAD+ Lab Procurement Guide — this article examines published research context, laboratory applications, and procurement notes for NAD+ (100mg / 500mg / 1000mg) in Mitochondrial Research programs at Sulan Peptide Official.
NAD+ is nicotinamide adenine dinucleotide used in laboratory research on cellular redox systems, mitochondrial pathway models, coenzyme-dependent reactions, and metabolic signaling studies.
Sulan Peptide lists NAD+ in the Mitochondrial Research category for buyers reviewing cellular redox and coenzyme-related research products, available formats, Cat No. details, and structured quotation information.
Available NAD+ formats include 100mg, 500mg, and 1000mg options. The product page provides molecular specifications, purity target, appearance, storage guidance, pricing references, and quote-cart support for research-use procurement.
100mg, 500mg, or 1000mg per kit, as selected
NAD+ serves as coenzyme for sirtuins, PARPs, and redox enzymes; exogenous NAD+ in culture supports sirtuin deacetylase activity assays and mitochondrial respiration studies.
Research tracks NAD+/NADH ratios during aging cell models and reprogramming experiments requiring defined coenzyme concentrations.
Enzymatic cycling assays, sirtuin activity kits with acetylated peptide substrates, and LC-MS metabolomics quantify NAD+ pool dynamics.
Sinclair lab and broader aging research literature use NAD+ precursors and NAD+ itself to probe sirtuin-dependent stress responses in cell models.
Lab procurement workflow: Open the NAD+ detail page under Mitochondrial Research on sulan-peptide.shop. Lock specification (100mg / 500mg / 1000mg), available COA rows, and Cat No. before raising an internal requisition. Include destination country and quantity when messaging Sulan Peptide Official at sales@sulan-peptide.shop or WhatsApp +447599352109.
Read the overview titled “What is NAD+?” together with the specification table for NAD+. Many PIs approve SKUs only after mechanism fit is written into the study plan.
For multi-phase work with NAD+, reference prior lot numbers in reorder notes when assay comparability depends on batch continuity.
Dose–response studies with NAD+ typically span log-scale concentrations; your protocol should state whether dosing is by mass (100mg / 500mg / 1000mg) or molarity derived from molecular weight on the product page.
Published Mitochondrial Research papers often include positive and negative assay controls alongside NAD+; budget control compounds before ordering experimental material.
When designing multi-arm studies, randomize vial lot assignment and blind analysts to supplier identity until primary readouts are locked—this reduces bias in vendor comparison experiments involving NAD+.
Literature searches for NAD+ should use both trade names and CAS 53-84-9 to capture mechanistic papers missed by supplier marketing keywords alone.
Pilot experiments with NAD+ often start at mid-range catalog specifications (100mg / 500mg / 1000mg) before scaling quantity for full study cohorts.
Cell viability panels should precede mechanism assays when introducing NAD+ to new cell lines—unexpected toxicity may reflect solvent choice rather than peptide sequence.
For long-horizon Mitochondrial Research projects, document freezer location and thaw count on every aliquot label tied to NAD+ lot numbers.
Appearance notes (White Lyophilized Powder) help detect moisture exposure or handling damage during receiving inspection of NAD+.
Catalog specification data for NAD+ lists CAS 53-84-9, Molecular formula C21H27N7O14P2. molecular weight 663.4 g/mol, and purity target ≥ 99.0%. Match these identifiers to incoming COA documents and internal sample labels before assay use.
Supplier storage guidance for NAD+: Store at -20°C, in a cool and dry place. Log receipt date, lot number, and freezer location when material enters your inventory. Plan aliquots before reconstitution to limit freeze-thaw cycles during multi-week assay series.
Available NAD+ research formats on sulan-peptide.shop include 100mg10vials, 500mg10vials, 1000mg*10vials. Cat No. references (NJ100, NJ500, NJ1000) should appear on requisitions so quoted material matches the specification selected during protocol design.
Purity target ≥ 99.0% on the catalog is a specification goal—your QA team should confirm the specific lot COA meets internal thresholds before release.
When NAD+ appears in combination with other peptides, cite each sequence’s Cat No. in publications to satisfy reproducibility standards in Mitochondrial Research journals.
Statistical plans should pre-register primary endpoints before unblinding NAD+ treatment arms in preclinical models.
Shipping seasonality can affect lyophilized cake integrity for NAD+; inspect vials after extreme transit delays even if COA predates shipment.
Training records for staff handling NAD+ should cover reconstitution math, RUO policy, and spill cleanup for research laboratories.
Internal IRB or IACUC protocols should cite RUO scope explicitly when NAD+ appears in animal or human-derived tissue research models.
Compare published assay incubation times for NAD+; overnight versus short pulses can invert apparent potency rankings in receptor assays.
NAD+ supplied by Sulan Peptide Official is research-use only (RUO)—not for human or veterinary use, diagnosis, or treatment. For specification or quotation questions, use the Contact page or WhatsApp on sulan-peptide.shop.